◆ 会议时间：2021年10月20日至23日
◆ 会议地点：美国 沃思堡/Ft. Worth, TX
◆ 会议简介：
2021年第37届美国骨科创伤协会(OTA)年会将于2021年10月20日至23日在美国德克萨斯州沃思堡举行。
美国骨科创伤协会(OTA)成立于1984年，其宗旨是通过提供科学论坛和支持肌肉骨骼系统的研究及骨外科医师和公众的教育来促进对受伤病人的护理。OTA年会是致力于肌肉骨骼创伤护理科学和教育发展的重要平台，有近两千名来自世界各地的专业人士与会（未经许可，禁止复制摘录转载本站任何内容-领域国际医学会议网）。
摘要提交：
Submission Deadline: February 3, 2021 at 11:59 PM CST
点此提交摘要>>>Submit Abstract>>>
Share your knowledge with orthopaedic surgeons from around the world at the 2021 OTA Annual Meeting.
SUBMISSION CATEGORIES
Paper: Paper presentations are six minutes in length. There is not a separate submission form for posters. The OTA Program Committee will determine the most effective presentation method, either paper or poster.
Breakout: One main topic with a moderator and 3 to 4 faculty. Open to questions from the audience. This includes case presentations. Concurrent breakout sessions are held throughout the meeting — 60 min in length.
Main Symposium: One main topic with a moderator and 3 to 5 faculty. Leave room for discussion and questions at the end of the session. This is held in the general session room with no conflicting sessions — 90 min in length.
Technical Tricks and Innovation: This category showcases innovative techniques and technologies and consists of case reports showing unique solutions to difficult problems.
The abstract shows a description of preliminary findings using new technology. This category is not designed to serve as an advertisement for a particular commercial product, so please avoid the appearance of commercial bias. You cannot submit your abstract to both this category and the paper category. You must choose one category.
Presentation will be a single slide (similar to a poster) displayed digitally throughout the course of the meeting.
IMPORTANT NOTE: Complete author disclosure is required for all submissions. Disclosures must be dated October 20, 2020 or later. Any disclosures made before this date will not be valid. There will be a 7-day author disclosure grace period from the close of abstract submissions. If an abstract does not have complete author disclosure by February 10, 2021, the abstract will not be reviewed by the OTA Program Committee. This includes breakout, main symposium, and technical tricks and innovation submissions. The name of the author must match exactly what is in the AAOS database to integrate with the author’s disclosure.
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
